SHR-A1904 for Injection

DRUG2 trials

Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Conditions

Biliary Tract CancerGastric CancerGastroesophageal-junction Cancer

Phase 2

A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

RecruitingNCT07110571

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Gastric Cancer, Gastroesophageal-junction Cancer

Start: 2025-08-28End: 2027-05-31Target: 200Updated: 2026-01-09

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

RecruitingNCT07450976

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Biliary Tract Cancer

Start: 2026-03-25End: 2030-12-01Target: 151Updated: 2026-03-31